Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma

Published:2004-10 Issue:2 Volume:60 Page:437-443
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Moutardier Vincent,Magnin Valérie,Turrini Olivier,Viret Frédéric,Hennekinne-Mucci Stephanie,Gonçalves Antony,Pesenti Christian,Guiramand Jérome,Lelong Bernard,Giovannini Marc,Monges Geneviève,Houvenaeghel Gilles,Delpero Jean-Robert

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference28 articles.

1. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma;Snady;Cancer,2000

2. Cost analysis of pancreatic carcinoma treatment;Du;Cancer,2000

3. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer;Cancer,1987

4. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer;Neoptolemos;Lancet,2001

5. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas;Spitz;J Clin Oncol,1997

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiochemotherapy in Pancreatic Cancer;Current Oncology;2024-06-06

2. Type of neoadjuvant treatment strategy is associated with differential pathologic responses in pancreatic ductal adenocarcinoma;The American Journal of Surgery;2023-11

3. M0 pancreatic cancer: treatment and prognosis by primary site;2022-10-10

4. Irreversible electroporation plus chemotherapy versus chemotherapy alone as treatments for patients with locally advanced pancreatic cancer;Hepatobiliary & Pancreatic Diseases International;2022-02

5. DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer;BioMed Research International;2021-03-02